PC
PBYI icon

Paulson & Co’s Puma Biotechnology PBYI Stock Holding History

Paulson & Co’s Portfolio PBYI Stock Details PBYI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-27,500
Closed -$2.4M – 80
2017
Q2 		$2.4M Buy
27,500
+11,810
+75% +$661K 0.03% 91
2017
Q1 		$584K Hold
15,690
– – 0.01% 94
2016
Q4 		$482K Sell
15,690
-68,810
-81% -$2.98M 0.01% 96
2016
Q3 		$5.67M Sell
84,500
-61,300
-42% -$3.1M 0.06% 69
2016
Q2 		$4.34M Buy
145,800
+75,500
+107% +$2.36M 0.04% 67
2016
Q1 		$2.06M Buy
70,300
+24,300
+53% +$1.1M 0.02% 82
2015
Q4 		$3.61M Buy
+46,000
New +$3.61M 0.02% 60

Other funds holding PBYI

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
O
OrbiMed New York $4.59B AUM 125.28% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $950M AUM 57.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $141B AUM 30.34% 1-Year Est. Return